Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials

Telocytes, a novel mesenchymal cell population, are characterized by their distinctive long and slender projections known as telopodes and have garnered significant interest since their formal introduction to the literature in 2010. These cells have been identified in various tissues, including the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ronaldo Paolo Panganiban, Christina McAninch, Marina Chulkina, Irina V. Pinchuk
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2024.1452258/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850098510893940736
author Ronaldo Paolo Panganiban
Christina McAninch
Marina Chulkina
Irina V. Pinchuk
author_facet Ronaldo Paolo Panganiban
Christina McAninch
Marina Chulkina
Irina V. Pinchuk
author_sort Ronaldo Paolo Panganiban
collection DOAJ
description Telocytes, a novel mesenchymal cell population, are characterized by their distinctive long and slender projections known as telopodes and have garnered significant interest since their formal introduction to the literature in 2010. These cells have been identified in various tissues, including the gastrointestinal (GI) tract, where they are suggested to play important roles in maintaining structural integrity, immune modulation, and barrier function. Inflammatory bowel diseases (IBD), which include Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by chronic inflammation and fibrosis. While limited information is available on the fate of telocytes in this group of diseases, it has been suggested that loss/plasticity of telocytes can be among the key factors contributing to their pathogenesis. This review focuses on the current understanding of telocytes, their structural features, and their distribution within the GI tract under gut homeostasis and IBD. We also discuss the roles of these cells in immune regulation and intestinal repair. We highlight evidence implicating telocytes in the pathogenesis of IBD and other chronic inflammatory diseases that share similar pathophysiological processes with IBD. Lastly, we discuss the current challenges in gut telocyte biology and the potential therapeutic implications of telocytes in IBD.
format Article
id doaj-art-b108a490a6434a079a030ddbcb06419f
institution DOAJ
issn 2296-634X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj-art-b108a490a6434a079a030ddbcb06419f2025-08-20T02:40:42ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-01-011210.3389/fcell.2024.14522581452258Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentialsRonaldo Paolo PanganibanChristina McAninchMarina ChulkinaIrina V. PinchukTelocytes, a novel mesenchymal cell population, are characterized by their distinctive long and slender projections known as telopodes and have garnered significant interest since their formal introduction to the literature in 2010. These cells have been identified in various tissues, including the gastrointestinal (GI) tract, where they are suggested to play important roles in maintaining structural integrity, immune modulation, and barrier function. Inflammatory bowel diseases (IBD), which include Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by chronic inflammation and fibrosis. While limited information is available on the fate of telocytes in this group of diseases, it has been suggested that loss/plasticity of telocytes can be among the key factors contributing to their pathogenesis. This review focuses on the current understanding of telocytes, their structural features, and their distribution within the GI tract under gut homeostasis and IBD. We also discuss the roles of these cells in immune regulation and intestinal repair. We highlight evidence implicating telocytes in the pathogenesis of IBD and other chronic inflammatory diseases that share similar pathophysiological processes with IBD. Lastly, we discuss the current challenges in gut telocyte biology and the potential therapeutic implications of telocytes in IBD.https://www.frontiersin.org/articles/10.3389/fcell.2024.1452258/fulltelocytefibrosisIBDulcerative colitisCrohn’s disease
spellingShingle Ronaldo Paolo Panganiban
Christina McAninch
Marina Chulkina
Irina V. Pinchuk
Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
Frontiers in Cell and Developmental Biology
telocyte
fibrosis
IBD
ulcerative colitis
Crohn’s disease
title Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
title_full Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
title_fullStr Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
title_full_unstemmed Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
title_short Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
title_sort telocytes in inflammatory bowel diseases contributions to pathology and therapeutic potentials
topic telocyte
fibrosis
IBD
ulcerative colitis
Crohn’s disease
url https://www.frontiersin.org/articles/10.3389/fcell.2024.1452258/full
work_keys_str_mv AT ronaldopaolopanganiban telocytesininflammatoryboweldiseasescontributionstopathologyandtherapeuticpotentials
AT christinamcaninch telocytesininflammatoryboweldiseasescontributionstopathologyandtherapeuticpotentials
AT marinachulkina telocytesininflammatoryboweldiseasescontributionstopathologyandtherapeuticpotentials
AT irinavpinchuk telocytesininflammatoryboweldiseasescontributionstopathologyandtherapeuticpotentials